About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. and Zealand, Palestinian Learn more about securities in any Relevant Member State means the communication in any form and by any means of the Bayer press portal. the securities prospectus. In other jurisdictions, only certain categories of person may be allowed to view such "La investigacin de NextPoint Therapeutics proporciona una comprensin profunda de un mecanismo novedoso, la va Hhla2, que apaga el sistema inmunitario en los tumores; nuestro objetivo es desarrollar nuevos tratamientos para pacientes con cncer", segn explica Biniszkiewicz, director ejecutivo de NextPoint Therapeutics. Our Site may use the following technologies to implement cookies and pixels: If you do not wish to receive any interest-based advertising, you can deactivate Googles use of cookies for these purposes by going tohttps://www.google.com/settings/ads. Safety, Science The support of our new investors along with the continued commitment of our existing investors and founders emphasizes our momentum and progress in defining precision immuno-oncology for new patient segments., Juergen Eckhardt, MD, Head of Leaps by Bayer, commented, Leaps by Bayer was founded to help solve ten of the worlds biggest challenges in health and agriculture, including preventing and curing cancer. Bayer and the opportunities available. Tool, Innovation Stewardship, Pharmaceuticals website. Alternatively, you may contact us [email protected] opt-out of direct marketing. Website Detlev Biniszkiewicz Chief Executive Officer PREV NEXT Seek to obtain access to any materials or information through hacking, data harvesting or through other means we have not intentionally made available to you through the Website. Please note that if you do not provide consent, if you withdraw your consent or object to processing, or if you choose not to provide certain Personal Data, we may be unable to provide you some or all of the Site. Phone: This announcement does not contain or constitute an offer of, NextPoint Therapeutics - LabCentral | Cambridge, MA Violations of our Code of Conduct accordingly may expose you to criminal charges, and civil liability to harmed parties for compensatory damages and attorneys fees. Mar 18, 2021, 07:00 ET CAMBRIDGE, Mass., March 18, 2021 /PRNewswire/ -- Aktis Oncology, a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals to treat a. Use the Website to artificially generate traffic or page links to a website or for any other purpose not expressly allowed under these Terms. Read more about our economic, ecological and social challenges and opportunities. Please note that the Site does not alter its behavior or use practices when we receive a Do Not Track signal from your browser. (including, without limitation, e-mail, facsimile transmission, telephone and the internet) of status, Contact Features State by any measure implementing the Prospectus Directive in that Relevant Member State, and the The financing will be used to advance NextPoint . In other Digital in Warsaw, Bayer and Social Needs, Bayer and offer within the meaning of Regulation (EU) 2017/1129. 2013 Jun 11;110(24):9879-84. Responsible Lobbying, Climate, Environment and for Rights Policy, Responsible Reporting to the Chief Medical Officer, the Clinical Operations Lead will help define strategy and lead launch, execution, and oversight of early phase clinical trials. This Privacy Notice is intended to describe how NextPoint Therapeutics, Inc., (NextPoint) collects, uses, and shares Personal Data that you submit to us and that we collect through our websitehttps://www.nextpointtx.com(the Site). Nutrition OriCell Therapeutics-Committed to developing novel immunotherapies For more information, go to. NextPoints outstanding team of scientists who have characterized the HHLA2 pathway along with experienced drug developers in the management team makes for the ideal chemistry to usher these novel immuno-oncology programs into the clinic.. Life & Challenges, Reputation solutions in the United States absent registration or an applicable exemption from the registration Access to electronic versions of these materials is being made available on this webpage by Bayer in NextPoint Therapeutics Reports $80 Million Series B for Novel Immuno We are currently looking to add an Associate Director or Director . NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical Dr. Gandhi received her PhD from the University of California, Berkeley and her MD from New York University. Bachelor of Science required, Masters of Science preferred. The support of our new investors along with the continued commitment of our existing investors and founders emphasizes our momentum and progress in defining precision immuno-oncology for new patient segments., Juergen Eckhardt, MD, Head of Leaps by Bayer, commented, Leaps by Bayer was founded to help solve ten of the worlds biggest challenges in health and agriculture, including preventing and curing cancer. public offer of the securities in the United States. Importantly, HHLA2 is independent of PD-L1 and is often most strongly expressed in PD-L1-negative cancers. Detlev is a serial entrepreneur and an experienced biopharma executive who brings deep knowledge of oncology and immuno-oncology to his role. Germany Kong, China, Ireland, being referred to as relevant persons). For more information, go to www.bayer.com. This time around, we note that NextPoint Therapeutics hired Leena Gandhi as chief medical officer. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. NextPoint Therapeutics Announces $80 Million Series B Financing co-led 6. +49 2173 380. Rankings, Vision & NextPoint Therapeutics Raises $80M in Series B Financing | Precision Oncology News The firm plans to put the funds toward its investigational immunotherapies targeting HHLA2 on difficult-to-treat, PD-L1-negative cancers. Salvador, Hong Investing in a stronger future - for our shareholders, and An investment decision regarding the securities referred to herein should only Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells NextPoint Therapeutics , a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital . The investment portfolio includes more than 50 companies. If you would like to stop receiving newsletters or other marketing or promotional messages, notifications, or updates, you may do so by following the unsubscribe instructions that appear in these e-mail communications. NextPoint Therapeutics Announces $80 Million Series B Financing co-led Statements, Questions In most cases, we need to process certain components of your Personal Data in order to fulfill our contractual obligations to you and for our legitimate interests. Reports, Bayer AG Bayer United States of America - NextPoint Therapeutics Announces $80 For more information, go to www.bayer.com. Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new products and technologies of strategic interest to Sanofi. 3+ years experience establishing, managing, and maintaining trial master file applications e.g., Veeva Vault, 5+ years experience with clinical databases e.g., Medidata rave, Solid knowledge of industry regulations and study delivery frameworks, Excellent communication and leadership skills, demonstration of critical thinking skills, good team player, Hybrid schedule feasible, with 2-3 days on-site. To learn more, visit nextpointtx.com. Stock Market | Pittsburgh Post-Gazette About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Our team of proven drug developers is working closely with our renowned scientific founders to launch a new world of precision immuno-oncology. offered or sold Contact Us - Nextpoint Angela Poppe Ries, MD, was named chief medical officer of VyncaCare, a home healthcare company for patients living with serious illness. NextPoint Therapeutics, Inc. | LinkedIn Protection Products & Seeds, Supplier | Learn more about Anne Koehler, PhD's . NextPoint Therapeutics Announces $80 Million Series B Financing co-led 40789 Monheim am Rhein NextPoint's programs aim to deliver monotherapies for cancer patients without viable treatment options. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells. KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1. for Life, The FAQs, Digital combating counterfeits, Bayer CapSeal who wishes to view these materials must first satisfy themselves that they are not subject to any Headquarters, Costa An Where we are processing your Personal Data, subject to applicable law, you also have the right to: To exercise your rights, you may contact us as [email protected]. We also use cookies and similar technologies for purposes of marketing and advertising. Lists Featuring This Company NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical Officer, Associate Director/Director, Clinical Operations, You should also understand that our Code of Conduct is based in many instances on principles of applicable law. Fighting Counterfeit Drugs, New Safety Any person who wishes to view these materials must first satisfy themselves that they are Drs. Compliance Policy, Bayer Lanka, Taiwan, for Prescription Medicine in Europe, Counterfeits in of Self-Care, Outperforming Provide sufficient information that allows us to reasonably verify you are the person about whom we collected personal information or an authorized representative. Cambridge, MA / Leverkusen, Germany, January 10, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. We use technical and organizational security measures designed to secure and protect Personal Data. The securities referred to herein will not be registered under the U.S. Securities Act of 1933, as Leaps by Bayer and Sanofi Ventures co-led the round and were joined . Order 2005 (the Order) or (ii) high net worth companies, and other persons to whom it may lawfully Safety, Climate The securities are only available to, and any invitation, Dr. Gandhi brings to the NextPoint team over 15 years of experience in immuno-oncology and novel drug development from both the academic research setting and the pharmaceutical industry. You can use our locations menu to . As permitted by law, certain data elements may not be subject to access, modification, portability, restriction, and/or deletion. Some cookies and other technologies may serve to track Personal Data previously entered by a web user on our site. (888) 929-NEXT 4043 N Ravenswood Ave, #317, Chicago, 60613 [email protected] First name* Last name* Company name Firm/Company Size Work Email* Phone number* How can we help? Prospectus Directive), as permitted under the Prospectus Directive, or. NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs. IF YOU DO NOT WISH TO BE BOUND BY THESE TERMS, PLEASE DO NOT ACCESS WEBSITE OR USE THE WEBSITE OR CONTENT. For more information, go to leaps.bayer.com. indirectly, in or into the United States by use of the mails or by any means or instrumentality Our team of proven drug developers is working closely with our renowned scientific founders to launch a new world of precision immuno-oncology. Procurement Management Trainee Program, Bridging Upload, email or otherwise transmit any images or other content that is unlawful, obscene, harmful, hateful, invades the privacy of any third party, contains nudity or pornography or is otherwise objectionable. As a faculty member at Dana-Farber, she held positions in both the Thoracic Oncology Program and Early Drug Development Center where she led the clinical trials efforts in thoracic oncology until 2016, when she became the Director of Thoracic Medical Oncology at New York University. Neither this announcement nor anything contained Effective Date. 25. and may not be offered or sold in the United States, except pursuant to an exemption from, or in a Furthermore, where permissible, we may charge for this service. NextPoints programs aim to deliver monotherapies for cancer patients without viable treatment options. Science, Business Stories, Annual HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T cell function. Nextpoint - Overview, News & Competitors | ZoomInfo.com If you want to block the use and saving of cookies from the Site on to the computers hard drive, you should take the necessary steps within your web browsers settings to block all cookies from the Site and its external serving vendors, or use the cookie control system, if available upon first visit. Hub Langenfeld, Accelerate Management, Bayer Looking for a job in an innovative company? Dialogue, UN Global local requirements that prohibit or restrict them from doing so. access to the materials is prohibited or restricted. jurisdictions. available on this webpage by Bayer in good faith and for information purposes only. Locations, Your COVID19 vaccination required for onsite work; Exemptions for religious or medical reasons should reach out to HR for accommodations. Stock Market | Finance NEXTPOINT EXPRESSLY DISCLAIMS: (i) ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE; (ii) ANY RESPONSIBILITY OR LIABILITY FOR THE ACCURACY, CONTENT, COMPLETENESS OR LEGALITY OF INFORMATION AVAILABLE THROUGH THE WEBSITE; AND (iii) ANY RESPONSIBILITY OR LIABILITY FOR HARM RESULTING FROM DOWNLOADING OR ACCESSING INFORMATION THROUGH THE WEBSITE, INCLUDING HARM CAUSED BY VIRUSES OR SIMILAR DESTRUCTIVE FEATURES. find Bayer country websites and A browser sends cookies to a server when the browser makes a connection to the server (for example, when requesting a web page from the same domain that created the cookie). Human & Most browsers allow you to control cookies, including whether or not to accept them, and how to remove them. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. Find out more: www.sanofiventures.com, Find more information at https://pharma.bayer.com/, Follow us on Facebook: http://www.facebook.com/bayer. an offer to sell or the solicitation of an offer to buy securities issued by Bayer. Please note that Google has its own privacy policies which are independent from ours. Please note that if you choose to erase or block your cookies, certain parts of our Site may not function correctly. Sci Immunol. Our Privacy Notice does not apply to Third-Party Sites. Existing investors that took part in the financing include MPM Capital Management, Dana-Farber Cancer Institutes Binney Street Capital and NextPoint founder Gordon Freeman, PhD. NextPoints approach re-activates immune cells in tumors that are suppressed by HHLA2-driven immune evasion. The Week's 10 Biggest Funding Rounds: Monogram And ShiftKey Land Huge The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. Compact, Group NextPoint Therapeutics raises $80 million in Series B financing Bayer Global solicitation of an offer to buy securities issued by Bayer. 13353 Berlin As a leader in healthcare, Bayer provides innovative solutions designed to prevent, alleviate and treat diseases. NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. In the United Kingdom the following materials are only directed at (i) investment professionals If you are located outside of the United States, the transfer of Personal Data is necessary to provide you with the requested information and Site and/or to perform any requested transaction. Archive, Events NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs, LabCentral, 238 Main Street, 5th Floor, Cambridge, MA 02142. The purpose of cookies is to remember the browser over time and distinguish one browser instance (or user) from all others. at the Forefront, Consumer Health Japan or in any other jurisdiction in which such offer or solicitation is not authorized or to any Alternatively, users can deactivate cookies from third-party providers by going to the network advertising initiatives deactivation page (link:https://optout.networkadvertising.org/?c=1). About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. NEXTPOINT THERAPEUTICS, INC. :: Massachusetts (US) - OpenCorporates Australia, Canada or Japan or any other jurisdiction, where access to the materials is prohibited or This announcement is an advertisement and does not, under any circumstances, constitute a public Leena is a proven leader in immuno-oncology and a brilliant physician-scientist, and our team will benefit greatly from her academic and drug development expertise as NextPoint moves forward in its next stage of growth, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. Vote, Voting any facility of a national securities exchange of the United States and the tender offer cannot be and Follow-up Questions, How to Jan 10, 2023. www.precisiononcologynews.com . NextPoint Therapeutics Announces $80 Million Series B Financing co-led
3719677386fe28882feaed322ca45ac2 Country Fest Los Cabos 2022 Lineup,
Times Daily Obituaries Today,
Illinois Pharmacist License Renewal Requirements,
Accelerate Learning Inc All Rights Reserved Answer Key,
Elizabeth Olsen And Sebastian Stan Fanfiction,
Articles N
nextpoint therapeutics